WEED, INC.

WEED, Inc. operates as a multi-national bio-pharmaceutical and real estate holding company focused on researching, developing, and applying cannabis-derived compounds for medical and industrial use. Through its operating subsidiaries, the company conducts cannabis genomic studies and breeding programs to classify the cannabis plant genus, preserve genetic cultivars, and develop validated strains aimed at treating human and animal ailments. It also holds a proprietary seedbank of cannabis and hemp genetics, maintains industrial hemp licenses for cultivation, nursery, and processing operations, and explores digital asset and technology integrations. Its primary targets and intended clientele include medical research centers, bio-pharmaceutical companies, healthcare professionals, and commercial medicinal markets.

The company maintains real estate assets, notably a 44-acre parcel with water extraction rights in Portland, New York, intended for future entry into hemp and infused beverage markets. WEED, Inc. has active subsidiary operations in the United States and Israel, and it is headquartered in Tucson, Arizona.

Summary of the business section of WEED's latest annual report, written by StockData.

“As of December 31, 2025, we employed two people on a full time basis, namely Glenn E.”